Christopher David Ozeroff Insider Profile
4 Followers
Christopher David Ozeroff, S.V.P., General Counsel at Oruka Therapeutics, holds 50.97K shares in Oruka Therapeutics (Ticker: ORKA). Most recently, Christopher David Ozeroff Bought 50,000 shares of Oruka Therapeutics on Nov 23, 2021 for an estimated value of $113.00K.
Christopher David Ozeroff's Trading History
| ORKAOruka Therapeutics | Nov 23, 2021 | S.V.P., General Counsel | Informative Buy | 113.00K | $5.06M | |
ORKA Insider Shares: 50.97K (0.35%) | ||||||
You May Also Like
Christopher David Ozeroff insider profile FAQ
What stocks does Christopher David Ozeroff hold?
Christopher David Ozeroff holds: ORKA stocks.
What was Christopher David Ozeroff’s latest transaction?
Christopher David Ozeroff’s latest transaction was an Informative Buy of $113.00K.
What is Christopher David Ozeroff's role in Oruka Therapeutics?
Christopher David Ozeroff's role in Oruka Therapeutics is S.V.P., General Counsel.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
